In this episode of Koggno Stories, I interview and Dr. Simon Erridge explore how far cannabis-based medicine has come since 2018, but also how far we still have to go.
We discuss the realities of prescribing cannabis-based medical products, the difference between medical cannabis and high-street CBD, and why confusion, stigma, and regulation still hold patients back from accessing treatment.
The UK’s journey since medical cannabis legalisation
How cannabis-based medicines differ from opioids and traditional pain relief
The role of cannabis in pain management, psychiatry and neurology
What the latest research and patient data are revealing
Whether you’re a clinician, patient, or just curious about the science behind medical cannabis, this conversation will leave you more informed — and more curious — about the future of prescribing in the UK.
Follow, rate, and share to help us grow the conversation and bring clarity to one of the most misunderstood areas of modern medicine.
Keywords:
medical cannabis UK, cannabis-based medicines, Curaleaf, cannabis research UK, medical marijuana UK, CBD vs THC, cannabis for pain, mental health, epilepsy, cannabis prescription UK, medical cannabis podcast, Koggno Stories